Regulatory T-Cell Differentiation and Their Function in Immune Regulation

  • Miranda Piccioni
  • Zuojia Chen
  • Andy Tsun
  • Bin Li
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 841)


Regulatory T-cells (Treg) represent a subset of CD4+ T-cells characterized by high suppressive capacity, which can be generated in the thymus or induced in the periphery. The deleterious phenotype of the Scurfy mouse, which develops an X-linked lymphoproliferative disease resulting from defective T-cell tolerance, clearly demonstrates the importance of Treg cells for the maintenance of immune homeostasis. Although significant progress has been achieved, much information regarding the development, characteristics and function of Treg cells remain lacking. This chapter highlights the most recent discoveries in the field of Treg biology, focusing on the development and role of this cell subset in the maintenance of immune balance.


Treg Development Characteristics Function 


  1. 1.
    Adeegbe D, Matsutani T et al (2010) CD4(+) CD25(+) Foxp3(+) T regulatory cells with limited TCR diversity in control of autoimmunity. J Immunol 184(1):56–66PubMedCentralPubMedGoogle Scholar
  2. 2.
    Akdis CA, Blaser K (2001) Mechanisms of interleukin-10-mediated immune suppression. Immunology 103(2):131–136PubMedCentralPubMedGoogle Scholar
  3. 3.
    Allan SE, Crome SQ et al (2007) Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol 19(4):345–354PubMedGoogle Scholar
  4. 4.
    Apostolou I, von Boehmer H (2004) In vivo instruction of suppressor commitment in naive T cells. J Exp Med 199(10):1401–1408PubMedCentralPubMedGoogle Scholar
  5. 5.
    Arpaia NC, Campbell et al. (2013) Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 7480:451–455Google Scholar
  6. 6.
    Atarashi K, Tanoue T et al (2011) Induction of colonic regulatory T-cells by indigenous Clostridium species. Science 331(6015):337–341PubMedCentralPubMedGoogle Scholar
  7. 7.
    Atarashi K, Tanoue T et al (2013) Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500(7461):232–236PubMedGoogle Scholar
  8. 8.
    Bacchetta R, Lucarelli B et al (2014) Immunological Outcome in haploidentical-HSC transplanted patients treated with IL-10-anergized donor T Cells. Front Immunol 5:16PubMedCentralPubMedGoogle Scholar
  9. 9.
    Bagavant H, Tung KS (2005) Failure of CD25+ T-cells from lupus-prone mice to suppress lupus glomerulonephritis and sialoadenitis. J Immunol 175(2):944–950PubMedGoogle Scholar
  10. 10.
    Banerjee A, Vasanthakumar A et al (2013) Modulating T regulatory cells in cancer: how close are we? Immunol Cell Biol 91(5):340–349PubMedGoogle Scholar
  11. 11.
    Barath S, Aleksza M et al (2007) Measurement of natural (CD4+ CD25high) and inducible (CD4+ IL-10+) regulatory T-cells in patients with systemic lupus erythematosus. Lupus 16(7):489–496PubMedGoogle Scholar
  12. 12.
    Barnes MJ, Krebs P et al (2009) Commitment to the regulatory T cell lineage requires CARMA1 in the thymus but not in the periphery. PLoS Biol 7(3):e51PubMedGoogle Scholar
  13. 13.
    Baron U, Floess S et al (2007) DNA demethylation in the human FOXP3 locus discriminates regulatory T-cells from activated FOXP3(+) conventional T cells. Eur J Immunol 37(9):2378–2389PubMedGoogle Scholar
  14. 14.
    Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136(2):215–233PubMedCentralPubMedGoogle Scholar
  15. 15.
    Battaglia M, Stabilini A et al (2006) Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T-cells of both healthy subjects and type 1 diabetic patients. J Immunol 177(12):8338–8347PubMedGoogle Scholar
  16. 16.
    Bazhin AV, Kahnert S et al (2010) Distinct metabolism of cyclic adenosine monophosphate in regulatory and helper CD4+ T cells. Mol Immunol 47(4):678–684PubMedGoogle Scholar
  17. 17.
    Bedner P, Niessen H et al (2006) Selective permeability of different connexin channels to the second messenger cyclic AMP. J Biol Chem 281(10):6673–6681PubMedGoogle Scholar
  18. 18.
    Beebe AM, Cua DJ et al (2002) The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS). Cytokine Growth Factor Rev 13(4–5):403–412PubMedGoogle Scholar
  19. 19.
    Bennett CL, Christie J et al (2001) The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27(1):20–21PubMedGoogle Scholar
  20. 20.
    Bettelli E, Das MP et al (1998) IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J Immunol 161(7):3299–3306PubMedGoogle Scholar
  21. 21.
    Bilate AM, Lafaille JJ (2012) Induced CD4+Foxp3+ regulatory T-cells in immune tolerance. Annu Rev Immunol 30:733–758PubMedGoogle Scholar
  22. 22.
    Bodor J, Feigenbaum L et al (2001) Suppression of T-cell responsiveness by inducible cAMP early repressor (ICER). J Leukoc Biol 69(6):1053–1059PubMedGoogle Scholar
  23. 23.
    Bopp T, Becker C et al (2007) Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression. J Exp Med 204(6):1303–1310PubMedCentralPubMedGoogle Scholar
  24. 24.
    Brunstein CG, Miller JS et al (2011) Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood 117(3):1061–1070PubMedCentralPubMedGoogle Scholar
  25. 25.
    Brusko T, Wasserfall C et al (2007) No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes. Diabetes 56(3):604–612PubMedGoogle Scholar
  26. 26.
    Burzyn D, Benoist C et al (2013) Regulatory T-cells in nonlymphoid tissues. Nat Immunol 14(10):1007–1013PubMedGoogle Scholar
  27. 27.
    Burzyn D, Kuswanto W et al (2013) A special population of regulatory T-cells potentiates muscle repair. Cell 155(6):1282–1295PubMedCentralPubMedGoogle Scholar
  28. 28.
    Cebula A, Seweryn M et al (2013) Thymus-derived regulatory T-cells contribute to tolerance to commensal microbiota. Nature 497(7448):258–262PubMedCentralPubMedGoogle Scholar
  29. 29.
    Chambers CA, Kuhns MS et al (2001) CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy. Annu Rev Immunol 19:565–594PubMedGoogle Scholar
  30. 30.
    Chatila TA, Blaeser F et al (2000) JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J Clin Invest 106(12):R75–R81PubMedCentralPubMedGoogle Scholar
  31. 31.
    Chaudhry A, Rudra D et al (2009) CD4+ regulatory T-cells control TH17 responses in a Stat3-dependent manner. Science 326(5955):986–991PubMedGoogle Scholar
  32. 32.
    Chen W, Jin W et al (2003) Conversion of peripheral CD4+CD25− naive T-cells to CD4+CD25+ regulatory T-cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198(12):1875–1886PubMedCentralPubMedGoogle Scholar
  33. 33.
    Cho JH, Gregersen PK (2011) Genomics and the multifactorial nature of human autoimmune disease. N Engl J Med 365(17):1612–1623PubMedGoogle Scholar
  34. 34.
    Chong MM, Rasmussen JP et al (2008) The RNAseIII enzyme Drosha is critical in T-cells for preventing lethal inflammatory disease. J Exp Med 205(9):2005–2017PubMedCentralPubMedGoogle Scholar
  35. 35.
    Chung Y, Tanaka S et al (2011) Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions. Nat Med 17(8):983–988PubMedCentralPubMedGoogle Scholar
  36. 36.
    Cipolletta D, Feuerer M et al (2012) PPAR-gamma is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature 486(7404):549–553PubMedCentralPubMedGoogle Scholar
  37. 37.
    Collison LW, Workman CJ et al (2007) The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450(7169):566–569PubMedGoogle Scholar
  38. 38.
    Collison LW, Chaturvedi V et al (2010) IL-35-mediated induction of a potent regulatory T cell population. Nat Immunol 11(12):1093–1101PubMedCentralPubMedGoogle Scholar
  39. 39.
    Crispin JC, Liossis SN et al (2010) Pathogenesis of human systemic lupus erythematosus: recent advances. Trends Mol Med 16(2):47–57PubMedCentralPubMedGoogle Scholar
  40. 40.
    Curiel TJ, Coukos G et al (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10(9):942–949PubMedGoogle Scholar
  41. 41.
    Curotto de Lafaille MA, Lino AC et al (2004) CD25− T cells generate CD25+Foxp3+ regulatory T cells by peripheral expansion. J Immunol 173(12):7259–7268PubMedGoogle Scholar
  42. 42.
    Curotto de Lafaille MA, Kutchukhidze N et al (2008) Adaptive Foxp3+ regulatory T cell-dependent and -independent control of allergic inflammation. Immunity 29(1):114–126PubMedGoogle Scholar
  43. 43.
    Curti A, Pandolfi S et al (2007) Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25− into CD25+ T regulatory cells. Blood 109(7):2871–2877PubMedGoogle Scholar
  44. 44.
    Datto MB, Frederick JP et al (1999) Targeted disruption of Smad3 reveals an essential role in transforming growth factor beta-mediated signal transduction. Mol Cell Biol 19(4):2495–2504PubMedCentralPubMedGoogle Scholar
  45. 45.
    Deaglio S, Dwyer KM et al (2007) Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 204(6):1257–1265PubMedCentralPubMedGoogle Scholar
  46. 46.
    Demir L, Yigit S et al (2013) Predictive and prognostic factors in locally advanced breast cancer: effect of intratumoral FOXP3+ Tregs. Clin Exp Metastasis 30(8):1047–1062PubMedGoogle Scholar
  47. 47.
    Di Ianni M, Falzetti F et al (2011) Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. Blood 117(14):3921–3928PubMedGoogle Scholar
  48. 48.
    Duhen T, Duhen R et al (2012) Functionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector Th cells. Blood 119(19):4430–4440PubMedCentralPubMedGoogle Scholar
  49. 49.
    Elkord E (2009) Frequency of human T regulatory cells in peripheral blood is significantly reduced by cryopreservation. J Immunol Methods 347(1–2):87–90PubMedGoogle Scholar
  50. 50.
    Etemire E, Krull M et al (2013) Transiently reduced PI3 K/Akt activity drives the development of regulatory function in antigen-stimulated Naive T-cells. PLoS ONE 8(7):e68378PubMedCentralPubMedGoogle Scholar
  51. 51.
    Fallarino F, Grohmann U et al (2006) The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells. J Immunol 176(11):6752–6761PubMedGoogle Scholar
  52. 52.
    Fantini MC, Becker C et al (2004) Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25− T cells through Foxp3 induction and down-regulation of Smad7. J Immunol 172(9):5149–5153PubMedGoogle Scholar
  53. 53.
    Feuerer M, Herrero L et al (2009) Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med 15(8):930–939PubMedCentralPubMedGoogle Scholar
  54. 54.
    Feuerer M, Hill JA et al (2009) Foxp3+ regulatory T cells: differentiation, specification, subphenotypes. Nat Immunol 10(7):689–695PubMedGoogle Scholar
  55. 55.
    Floess S, Freyer J et al (2007) Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol 5(2):e38PubMedCentralPubMedGoogle Scholar
  56. 56.
    Fohse L, Suffner J et al (2011) High TCR diversity ensures optimal function and homeostasis of Foxp3+ regulatory T cells. Eur J Immunol 41(11):3101–3113PubMedGoogle Scholar
  57. 57.
    Fontenot JD, Gavin MA et al (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4(4):330–336PubMedGoogle Scholar
  58. 58.
    Fontenot JD, Rasmussen JP et al (2005) A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 6(11):1142–1151PubMedGoogle Scholar
  59. 59.
    Friedlander MR, Lizano E et al (2014) Evidence for the biogenesis of more than 1,000 novel human microRNAs. Genome Biol 15(4):R57PubMedCentralPubMedGoogle Scholar
  60. 60.
    Furtado GC, Curotto de Lafaille MA et al (2002) Interleukin 2 signaling is required for CD4(+) regulatory T cell function. J Exp Med 196(6):851–857PubMedCentralPubMedGoogle Scholar
  61. 61.
    Furusawa Y, Obata Y et al (2013) Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504(7480):446–450PubMedGoogle Scholar
  62. 62.
    Gagliani N, Magnani CF et al (2013) Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells. Nat Med 19(6):739–746PubMedGoogle Scholar
  63. 63.
    Gavin MA, Torgerson TR et al (2006) Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc Natl Acad Sci USA 103(17):6659–6664PubMedCentralPubMedGoogle Scholar
  64. 64.
    Gazzinelli RT, Wysocka M et al (1996) In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. J Immunol 157(2):798–805PubMedGoogle Scholar
  65. 65.
    Glisic-Milosavljevic S, Waukau J et al (2007) At-risk and recent-onset type 1 diabetic subjects have increased apoptosis in the CD4+CD25+ T-cell fraction. PLoS ONE 2(1):e146PubMedCentralPubMedGoogle Scholar
  66. 66.
    Gobert M, Treilleux I et al (2009) Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome. Cancer Res 69(5):2000–2009PubMedGoogle Scholar
  67. 67.
    Goerner M, Gooley T et al (2002) Morbidity and mortality of chronic GVHD after hematopoietic stem cell transplantation from HLA-identical siblings for patients with aplastic or refractory anemias. Biol Blood Marrow Transplant 8(1):47–56PubMedGoogle Scholar
  68. 68.
    Gottschalk RA, Corse E et al (2010) TCR ligand density and affinity determine peripheral induction of Foxp3 in vivo. J Exp Med 207(8):1701–1711PubMedCentralPubMedGoogle Scholar
  69. 69.
    Govindaraj C, Scalzo-Inguanti K et al (2013) Impaired Th1 immunity in ovarian cancer patients is mediated by TNFR2+ Tregs within the tumor microenvironment. Clin Immunol 149(1):97–110PubMedGoogle Scholar
  70. 70.
    Grohmann U, Fallarino F et al (2003) Tolerance, DCs and tryptophan: much ado about IDO. Trends Immunol 24(5):242–248PubMedGoogle Scholar
  71. 71.
    Grohmann U, Volpi C et al (2007) Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy. Nat Med 13(5):579–586PubMedGoogle Scholar
  72. 72.
    Groux H, O’Garra A et al (1997) A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389(6652):737–742PubMedGoogle Scholar
  73. 73.
    Guo H, Ingolia NT et al (2010) Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466(7308):835–840PubMedCentralPubMedGoogle Scholar
  74. 74.
    Gupta S, Manicassamy S et al (2008) Differential requirement of PKC-theta in the development and function of natural regulatory T cells. Mol Immunol 46(2):213–224PubMedCentralPubMedGoogle Scholar
  75. 75.
    Hata H, Sakaguchi N et al (2004) Distinct contribution of IL-6, TNF-alpha, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice. J Clin Invest 114(4):582–588PubMedCentralPubMedGoogle Scholar
  76. 76.
    Hayashi T, Hasegawa K et al (2005) Elimination of CD4(+)CD25(+) T cell accelerates the development of glomerulonephritis during the preactive phase in autoimmune-prone female NZB × NZW F mice. Int J Exp Pathol 86(5):289–296PubMedCentralPubMedGoogle Scholar
  77. 77.
    Herman AE, Freeman GJ et al (2004) CD4+CD25+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion. J Exp Med 199(11):1479–1489PubMedCentralPubMedGoogle Scholar
  78. 78.
    Hindley JP, Ferreira C et al (2011) Analysis of the T-cell receptor repertoires of tumor-infiltrating conventional and regulatory T cells reveals no evidence for conversion in carcinogen-induced tumors. Cancer Res 71(3):736–746PubMedCentralPubMedGoogle Scholar
  79. 79.
    Hinterberger M, Aichinger M et al (2010) Autonomous role of medullary thymic epithelial cells in central CD4(+) T cell tolerance. Nat Immunol 11(6):512–519PubMedGoogle Scholar
  80. 80.
    Hoffmann P, Boeld TJ et al (2006) Isolation of CD4+CD25+ regulatory T cells for clinical trials. Biol Blood Marrow Transplant 12(3):267–274PubMedGoogle Scholar
  81. 81.
    Hori S, Haury M et al (2002) Specificity requirements for selection and effector functions of CD25+4+ regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice. Proc Natl Acad Sci USA 99(12):8213–8218PubMedCentralPubMedGoogle Scholar
  82. 82.
    Hori S, Nomura T et al (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299(5609):1057–1061PubMedGoogle Scholar
  83. 83.
    Hsieh CS, Liang Y et al (2004) Recognition of the peripheral self by naturally arising CD25+CD4+ T cell receptors. Immunity 21(2):267–277PubMedGoogle Scholar
  84. 84.
    Hsu WT, Suen JL et al (2006) The role of CD4CD25 T cells in autoantibody production in murine lupus. Clin Exp Immunol 145(3):513–519PubMedCentralPubMedGoogle Scholar
  85. 85.
    Hsu LY, Tan YX et al (2009) A hypomorphic allele of ZAP-70 reveals a distinct thymic threshold for autoimmune disease versus autoimmune reactivity. J Exp Med 206(11):2527–2541PubMedCentralPubMedGoogle Scholar
  86. 86.
    Hung T, Wang Y et al (2011) Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters. Nat Genet 43(7):621–629PubMedCentralPubMedGoogle Scholar
  87. 87.
    Isomura I, Palmer S et al (2009) c-Rel is required for the development of thymic Foxp3+CD4 regulatory T cells. J Exp Med 206(13):3001–3014PubMedCentralPubMedGoogle Scholar
  88. 88.
    Itoh M, Takahashi T et al (1999) Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol 162(9):5317–5326PubMedGoogle Scholar
  89. 89.
    Jailwala P, Waukau J et al (2009) Apoptosis of CD4+CD25(high) T cells in type 1 diabetes may be partially mediated by IL-2 deprivation. PLoS ONE 4(8):e6527PubMedCentralPubMedGoogle Scholar
  90. 90.
    Jordan MS, Boesteanu A et al (2001) Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat Immunol 2(4):301–306PubMedGoogle Scholar
  91. 91.
    Kerdiles YM, Stone EL et al (2010) Foxo transcription factors control regulatory T cell development and function. Immunity 33(6):890–904PubMedCentralPubMedGoogle Scholar
  92. 92.
    Khalil AM, Guttman M et al (2009) Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci USA 106(28):11667–11672PubMedCentralPubMedGoogle Scholar
  93. 93.
    Khattri R, Cox T et al (2003) An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 4(4):337–342PubMedGoogle Scholar
  94. 94.
    Kim HP, Leonard WJ (2007) CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation. J Exp Med 204(7):1543–1551PubMedCentralPubMedGoogle Scholar
  95. 95.
    Kim JM, Rasmussen JP et al (2007) Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol 8(2):191–197PubMedGoogle Scholar
  96. 96.
    Kitani A, Fuss I et al (2003) Transforming growth factor (TGF)-beta1-producing regulatory T cells induce Smad-mediated interleukin 10 secretion that facilitates coordinated immunoregulatory activity and amelioration of TGF-beta1-mediated fibrosis. J Exp Med 198(8):1179–1188PubMedCentralPubMedGoogle Scholar
  97. 97.
    Koch MA, Tucker-Heard G et al (2009) The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat Immunol 10(6):595–602PubMedCentralPubMedGoogle Scholar
  98. 98.
    Koonpaew S, Shen S et al (2006) LAT-mediated signaling in CD4+CD25+ regulatory T cell development. J Exp Med 203(1):119–129PubMedCentralPubMedGoogle Scholar
  99. 99.
    Kornete M, Sgouroudis E et al (2012) ICOS-dependent homeostasis and function of Foxp3+ regulatory T cells in islets of nonobese diabetic mice. J Immunol 188(3):1064–1074PubMedGoogle Scholar
  100. 100.
    Kretschmer K, Apostolou I et al (2005) Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 6(12):1219–1227PubMedGoogle Scholar
  101. 101.
    Ladoire S, Martin F et al (2011) Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer. Cancer Immunol Immunother 60(7):909–918PubMedGoogle Scholar
  102. 102.
    Lahl K, Loddenkemper C et al (2007) Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J Exp Med 204(1):57–63PubMedCentralPubMedGoogle Scholar
  103. 103.
    Lathrop SK, Bloom SM et al (2011) Peripheral education of the immune system by colonic commensal microbiota. Nature 478(7368):250–254PubMedCentralPubMedGoogle Scholar
  104. 104.
    Laurie KL, Van Driel IR et al (2002) The role of CD4+CD25+ immunoregulatory T cells in the induction of autoimmune gastritis. Immunol Cell Biol 80(6):567–573PubMedGoogle Scholar
  105. 105.
    Leon LR, Kozak W et al (1998) Role of IL-10 in inflammation. Studies using cytokine knockout mice. Ann N Y Acad Sci 856:69–75PubMedGoogle Scholar
  106. 106.
    Liao G, Nayak S et al (2010) GITR engagement preferentially enhances proliferation of functionally competent CD4+CD25+FoxP3+ regulatory T cells. Int Immunol 22(4):259–270PubMedCentralPubMedGoogle Scholar
  107. 107.
    Lin SC, Chen KH et al (2007) The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients. Eur J Clin Invest 37(12):987–996PubMedGoogle Scholar
  108. 108.
    Lin SZ, Chen KJ et al (2013) Prediction of recurrence and survival in hepatocellular carcinoma based on two Cox models mainly determined by FoxP3+ regulatory T cells. Cancer Prev Res (Phila) 6(6):594–602Google Scholar
  109. 109.
    Linterman MA, Pierson W et al (2011) Foxp3+ follicular regulatory T cells control the germinal center response. Nat Med 17(8):975–982PubMedCentralPubMedGoogle Scholar
  110. 110.
    Lio CW, Dodson LF et al (2010) CD28 facilitates the generation of Foxp3(-) cytokine responsive regulatory T cell precursors. J Immunol 184(11):6007–6013PubMedCentralPubMedGoogle Scholar
  111. 111.
    Liston A, Lu LF et al (2008) Dicer-dependent microRNA pathway safeguards regulatory T cell function. J Exp Med 205(9):1993–2004PubMedCentralPubMedGoogle Scholar
  112. 112.
    Liu W, Putnam AL et al (2006) CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 203(7):1701–1711PubMedCentralPubMedGoogle Scholar
  113. 113.
    Liu VC, Wong LY et al (2007) Tumor evasion of the immune system by converting CD4+CD25− T cells into CD4+CD25+ T regulatory cells: role of tumor-derived TGF-beta. J Immunol 178(5):2883–2892PubMedGoogle Scholar
  114. 114.
    Liu X, Robinson SN et al (2014) FOXP3 is a direct target of miR15a/16 in umbilical cord blood regulatory T cells. Bone Marrow Transplant 49(6):793–799PubMedGoogle Scholar
  115. 115.
    Loewer S, Cabili MN et al (2010) Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells. Nat Genet 42(12):1113–1117PubMedCentralPubMedGoogle Scholar
  116. 116.
    Lu LF, Thai TH et al (2009) Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity 30(1):80–91PubMedCentralPubMedGoogle Scholar
  117. 117.
    Lu LF, Boldin MP et al (2010) Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell 142(6):914–929PubMedCentralPubMedGoogle Scholar
  118. 118.
    Lu L, Ma J et al (2011) All-trans retinoic acid promotes TGF-beta-induced Tregs via histone modification but not DNA demethylation on Foxp3 gene locus. PLoS ONE 6(9):e24590PubMedCentralPubMedGoogle Scholar
  119. 119.
    Lyssuk EY, Torgashina AV et al (2007) Reduced number and function of CD4+CD25 high FoxP3+ regulatory T cells in patients with systemic lupus erythematosus. Adv Exp Med Biol 601:113–119PubMedGoogle Scholar
  120. 120.
    Macfarlane GT, Macfarlane S (1997) Human colonic microbiota: ecology, physiology and metabolic potential of intestinal bacteria. Scand J Gastroenterol Suppl 222:3–9PubMedGoogle Scholar
  121. 121.
    Makita S, Kanai T et al (2007) Intestinal lamina propria retaining CD4+CD25+ regulatory T cells is a suppressive site of intestinal inflammation. J Immunol 178(8):4937–4946PubMedGoogle Scholar
  122. 122.
    Mantel PY, Ouaked N et al (2006) Molecular mechanisms underlying FOXP3 induction in human T cells. J Immunol 176(6):3593–3602PubMedGoogle Scholar
  123. 123.
    Marek-Trzonkowska N, Mysliwiec M et al (2012) Administration of CD4+CD25 high CD127- regulatory T cells preserves beta-cell function in type 1 diabetes in children. Diabetes Care 35(9):1817–1820PubMedCentralPubMedGoogle Scholar
  124. 124.
    Marks SD, Tullus K (2012) Autoantibodies in systemic lupus erythematosus. Pediatr Nephrol 27(10):1855–1868PubMedGoogle Scholar
  125. 125.
    Marson A, Kretschmer K et al (2007) Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 445(7130):931–935PubMedCentralPubMedGoogle Scholar
  126. 126.
    McHugh RS, Whitters MJ et al (2002) CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16(2):311–323PubMedGoogle Scholar
  127. 127.
    Mestecky J, McGhee JR (1987) Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv Immunol 40:153–245PubMedGoogle Scholar
  128. 128.
    Miyara M, Amoura Z et al (2005) Global natural regulatory T cell depletion in active systemic lupus erythematosus. J Immunol 175(12):8392–8400PubMedGoogle Scholar
  129. 129.
    Miyara M, Yoshioka Y et al (2009) Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 30(6):899–911PubMedGoogle Scholar
  130. 130.
    Mucida D, Kutchukhidze N et al (2005) Oral tolerance in the absence of naturally occurring Tregs. J Clin Invest 115(7):1923–1933PubMedCentralPubMedGoogle Scholar
  131. 131.
    Nakamura K, Kitani A et al (2001) Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med 194(5):629–644PubMedCentralPubMedGoogle Scholar
  132. 132.
    Nakamura K, Kitani A et al (2004) TGF-beta 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice. J Immunol 172(2):834–842PubMedGoogle Scholar
  133. 133.
    Nelson BH, Willerford DM (1998) Biology of the interleukin-2 receptor. Adv Immunol 70:1–81PubMedGoogle Scholar
  134. 134.
    Nguyen LT, Jacobs J et al (2007) Where FoxP3-dependent regulatory T cells impinge on the development of inflammatory arthritis. Arthritis Rheum 56(2):509–520PubMedGoogle Scholar
  135. 135.
    Ohkura N, Hamaguchi M et al (2012) T cell receptor stimulation-induced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell development. Immunity 37(5):785–799PubMedGoogle Scholar
  136. 136.
    Olivares-Villagomez D, Wang Y et al (1998) Regulatory CD4(+) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis. J Exp Med 188(10):1883–1894PubMedCentralPubMedGoogle Scholar
  137. 137.
    Onishi Y, Fehervari Z et al (2008) Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc Natl Acad Sci USA 105(29):10113–10118PubMedCentralPubMedGoogle Scholar
  138. 138.
    Onizuka S, Tawara I et al (1999) Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody. Cancer Res 59(13):3128–3133PubMedGoogle Scholar
  139. 139.
    Ostman S, Rask C et al (2006) Impaired regulatory T cell function in germ-free mice. Eur J Immunol 36(9):2336–2346PubMedGoogle Scholar
  140. 140.
    Ouyang W, Beckett O et al (2010) Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells. Nat Immunol 11(7):618–627PubMedGoogle Scholar
  141. 141.
    Ouyang W, Liao W et al (2012) Novel Foxo1-dependent transcriptional programs control T(reg) cell function. Nature 491(7425):554–559PubMedCentralPubMedGoogle Scholar
  142. 142.
    Pacholczyk R, Kern J (2008) The T-cell receptor repertoire of regulatory T cells. Immunology 125(4):450–458PubMedCentralPubMedGoogle Scholar
  143. 143.
    Pacholczyk R, Ignatowicz H et al (2006) Origin and T cell receptor diversity of Foxp3+CD4+CD25+ T cells. Immunity 25(2):249–259PubMedGoogle Scholar
  144. 144.
    Pandiyan P, Zheng L et al (2007) CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells. Nat Immunol 8(12):1353–1362PubMedGoogle Scholar
  145. 145.
    Pandiyan P, Conti HR et al (2011) CD4(+)CD25(+)Foxp3(+) regulatory T cells promote Th17 cells in vitro and enhance host resistance in mouse Candida albicans Th17 cell infection model. Immunity 34(3):422–434PubMedCentralPubMedGoogle Scholar
  146. 146.
    Papiernik M (2001) Natural CD4+CD25+ regulatory T cells. Their role in the control of superantigen responses. Immunol Rev 182:180–189PubMedGoogle Scholar
  147. 147.
    Park HJ, Kusnadi A et al (2012) Tumor-infiltrating regulatory T cells delineated by upregulation of PD-1 and inhibitory receptors. Cell Immunol 278(1–2):76–83PubMedGoogle Scholar
  148. 148.
    Patterson SJ, Han JM et al (2011) Cutting edge: PHLPP regulates the development, function, and molecular signaling pathways of regulatory T cells. J Immunol 186(10):5533–5537PubMedCentralPubMedGoogle Scholar
  149. 149.
    Patton DT, Garden OA et al (2006) Cutting edge: the phosphoinositide 3-kinase p110 delta is critical for the function of CD4+CD25+Foxp3+ regulatory T cells. J Immunol 177(10):6598–6602PubMedGoogle Scholar
  150. 150.
    Peters JH, Preijers FW et al (2008) Clinical grade Treg: GMP isolation, improvement of purity by CD127 Depletion, Treg expansion, and Treg cryopreservation. PLoS ONE 3(9):e3161PubMedCentralPubMedGoogle Scholar
  151. 151.
    Putnam AL, Vendrame F et al (2005) CD4+CD25 high regulatory T cells in human autoimmune diabetes. J Autoimmun 24(1):55–62PubMedGoogle Scholar
  152. 152.
    Qiao YQ, Huang ML et al (2013) LncRNA DQ786243 affects Treg related CREB and Foxp3 expression in Crohn’s disease. J Biomed Sci 20:87PubMedCentralPubMedGoogle Scholar
  153. 153.
    Qin J, Li R et al (2010) A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464(7285):59–65PubMedCentralPubMedGoogle Scholar
  154. 154.
    Racke MK, Burnett D et al (1995) Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course. J Immunol 154(1):450–458PubMedGoogle Scholar
  155. 155.
    Rao S, Gerondakis S et al (2003) c-Rel is required for chromatin remodeling across the IL-2 gene promoter. J Immunol 170(7):3724–3731PubMedGoogle Scholar
  156. 156.
    Read S, Greenwald R et al (2006) Blockade of CTLA-4 on CD4+CD25+ regulatory T cells abrogates their function in vivo. J Immunol 177(7):4376–4383PubMedGoogle Scholar
  157. 157.
    Ronchetti S, Zollo O et al (2004) GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations. Eur J Immunol 34(3):613–622PubMedGoogle Scholar
  158. 158.
    Rouas R, Fayyad-Kazan H et al (2009) Human natural Treg microRNA signature: role of microRNA-31 and microRNA-21 in FOXP3 expression. Eur J Immunol 39(6):1608–1618PubMedGoogle Scholar
  159. 159.
    Ruan Q, Kameswaran V et al (2009) Development of Foxp3(+) regulatory t cells is driven by the c-Rel enhanceosome. Immunity 31(6):932–940PubMedCentralPubMedGoogle Scholar
  160. 160.
    Rubtsov YP, Rasmussen JP et al (2008) Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 28(4):546–558PubMedGoogle Scholar
  161. 161.
    Rudra D, deRoos P et al (2012) Transcription factor Foxp3 and its protein partners form a complex regulatory network. Nat Immunol 13(10):1010–1019PubMedCentralPubMedGoogle Scholar
  162. 162.
    Sadlack B, Kuhn R et al (1994) Development and proliferation of lymphocytes in mice deficient for both interleukins-2 and -4. Eur J Immunol 24(1):281–284PubMedGoogle Scholar
  163. 163.
    Sadlack B, Lohler J et al (1995) Generalized autoimmune disease in interleukin-2-deficient mice is triggered by an uncontrolled activation and proliferation of CD4+ T cells. Eur J Immunol 25(11):3053–3059PubMedGoogle Scholar
  164. 164.
    Salomon B, Lenschow DJ et al (2000) B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12(4):431–440PubMedGoogle Scholar
  165. 165.
    Samstein RM, Arvey A et al (2012) Foxp3 exploits a pre-existent enhancer landscape for regulatory T cell lineage specification. Cell 151(1):153–166PubMedCentralPubMedGoogle Scholar
  166. 166.
    Samstein RM, Josefowicz SZ et al (2012) Extrathymic generation of regulatory T cells in placental mammals mitigates maternal-fetal conflict. Cell 150(1):29–38PubMedCentralPubMedGoogle Scholar
  167. 167.
    Saoudi A, Seddon B et al (1996) The physiological role of regulatory T cells in the prevention of autoimmunity: the function of the thymus in the generation of the regulatory T cell subset. Immunol Rev 149:195–216PubMedGoogle Scholar
  168. 168.
    Sather BD, Treuting P et al (2007) Altering the distribution of Foxp3(+) regulatory T cells results in tissue-specific inflammatory disease. J Exp Med 204(6):1335–1347PubMedCentralPubMedGoogle Scholar
  169. 169.
    Sattui S, de la Flor C et al (2012) Cryopreservation modulates the detection of regulatory T cell markers. Cytometry B Clin Cytom 82(1):54–58PubMedGoogle Scholar
  170. 170.
    Savage PA, Malchow S et al (2013) Basic principles of tumor-associated regulatory T cell biology. Trends Immunol 34(1):33–40PubMedCentralPubMedGoogle Scholar
  171. 171.
    Scalapino KJ, Tang Q et al (2006) Suppression of disease in New Zealand Black/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells. J Immunol 177(3):1451–1459PubMedGoogle Scholar
  172. 172.
    Schmidl C, Klug M et al (2009) Lineage-specific DNA methylation in T cells correlates with histone methylation and enhancer activity. Genome Res 19(7):1165–1174PubMedCentralPubMedGoogle Scholar
  173. 173.
    Schmidt AM, Zou T et al (2013) Diacylglycerol kinase zeta limits the generation of natural regulatory T cells. Sci Signal 6(303):ra101Google Scholar
  174. 174.
    Schmidt-Supprian M, Courtois G et al (2003) Mature T cells depend on signaling through the IKK complex. Immunity 19(3):377–389PubMedGoogle Scholar
  175. 175.
    Seale AC, de Jong BC et al (2008) Effects of cryopreservation on CD4+CD25+ T cells of HIV-1 infected individuals. J Clin Lab Anal 22(3):153–158PubMedGoogle Scholar
  176. 176.
    Sell K, Barth PJ et al (2012) Localization of FOXP3-positive cells in renal cell carcinoma. Tumour Biol 33(2):507–513PubMedGoogle Scholar
  177. 177.
    Shevach EM, Stephens GL (2006) The GITR-GITRL interaction: co-stimulation or contrasuppression of regulatory activity? Nat Rev Immunol 6(8):613–618PubMedGoogle Scholar
  178. 178.
    Shi Y, Massague J (2003) Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113(6):685–700PubMedGoogle Scholar
  179. 179.
    Shimizu J, Yamazaki S et al (2002) Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 3(2):135–142PubMedGoogle Scholar
  180. 180.
    Siggs OM, Miosge LA et al (2007) Opposing functions of the T cell receptor kinase ZAP-70 in immunity and tolerance differentially titrate in response to nucleotide substitutions. Immunity 27(6):912–926PubMedCentralPubMedGoogle Scholar
  181. 181.
    Sledzinska A, Hemmers S et al (2013) TGF-beta Signalling Is Required for CD4(+) T Cell Homeostasis But Dispensable for Regulatory T Cell Function. PLoS Biol 11(10):e1001674PubMedCentralPubMedGoogle Scholar
  182. 182.
    Sobel ES, Brusko TM et al (2011) Defective response of CD4(+) T cells to retinoic acid and TGFbeta in systemic lupus erythematosus. Arthritis Res Ther 13(3):R106PubMedCentralPubMedGoogle Scholar
  183. 183.
    Somerset DA, Zheng Y et al (2004) Normal human pregnancy is associated with an elevation in the immune suppressive CD25+CD4+ regulatory T-cell subset. Immunology 112(1):38–43PubMedCentralPubMedGoogle Scholar
  184. 184.
    Stephens GL, McHugh RS et al (2004) Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells. J Immunol 173(8):5008–5020PubMedGoogle Scholar
  185. 185.
    Suen JL, Li HT et al (2009) Altered homeostasis of CD4(+)FoxP3(+) regulatory T-cell subpopulations in systemic lupus erythematosus. Immunology 127(2):196–205PubMedCentralPubMedGoogle Scholar
  186. 186.
    Suffia IJ, Reckling SK et al (2006) Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigens. J Exp Med 203(3):777–788PubMedCentralPubMedGoogle Scholar
  187. 187.
    Szymczak-Workman AL, Delgoffe GM et al (2011) Cutting edge: regulatory T cells do not mediate suppression via programmed cell death pathways. J Immunol 187(9):4416–4420PubMedCentralPubMedGoogle Scholar
  188. 188.
    Tai X, Cowan M et al (2005) CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat Immunol 6(2):152–162PubMedGoogle Scholar
  189. 189.
    Takahashi T, Tagami T et al (2000) Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 192(2):303–310PubMedCentralPubMedGoogle Scholar
  190. 190.
    Tanchot C, Terme M et al (2013) Tumor-infiltrating regulatory T cells: phenotype, role, mechanism of expansion in situ and clinical significance. Cancer Microenviron 6(2):147–157PubMedCentralPubMedGoogle Scholar
  191. 191.
    Teles A, Schumacher A et al (2013) Control of uterine microenvironment by foxp3(+) cells facilitates embryo implantation. Front Immunol 4:158PubMedCentralPubMedGoogle Scholar
  192. 192.
    Tivol EA, Borriello F et al (1995) Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3(5):541–547PubMedGoogle Scholar
  193. 193.
    Tran DQ, Ramsey H et al (2007) Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype. Blood 110(8):2983–2990PubMedCentralPubMedGoogle Scholar
  194. 194.
    Trzonkowski P, Bieniaszewska M et al (2009) First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127− T regulatory cells. Clin Immunol 133(1):22–26PubMedGoogle Scholar
  195. 195.
    Turner M, Galloway A et al (2014) Noncoding RNA and its associated proteins as regulatory elements of the immune system. Nat Immunol 15(6):484–491PubMedGoogle Scholar
  196. 196.
    Valencia X, Yarboro C et al (2007) Deficient CD4+CD25 high T regulatory cell function in patients with active systemic lupus erythematosus. J Immunol 178(4):2579–2588PubMedGoogle Scholar
  197. 197.
    Valzasina B, Piconese S et al (2006) Tumor-induced expansion of regulatory T cells by conversion of CD4+CD25− lymphocytes is thymus and proliferation independent. Cancer Res 66(8):4488–4495PubMedGoogle Scholar
  198. 198.
    van Santen HM, Benoist C et al (2004) Number of T reg cells that differentiate does not increase upon encounter of agonist ligand on thymic epithelial cells. J Exp Med 200(10):1221–1230PubMedCentralPubMedGoogle Scholar
  199. 199.
    Vargas-Rojas MI, Crispin JC et al (2008) Quantitative and qualitative normal regulatory T cells are not capable of inducing suppression in SLE patients due to T-cell resistance. Lupus 17(4):289–294PubMedGoogle Scholar
  200. 200.
    Venigalla RK, Tretter T et al (2008) Reduced CD4+,CD25− T cell sensitivity to the suppressive function of CD4+,CD25 high,CD127 -/low regulatory T cells in patients with active systemic lupus erythematosus. Arthritis Rheum 58(7):2120–2130PubMedGoogle Scholar
  201. 201.
    Viguier M, Lemaitre F et al (2004) Foxp3 expressing CD4+CD25 (high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. J Immunol 173(2):1444–1453PubMedGoogle Scholar
  202. 202.
    Wainwright DA, Dey M et al (2013) Targeting tregs in malignant brain cancer: overcoming IDO. Front Immunol 4:116PubMedCentralPubMedGoogle Scholar
  203. 203.
    Wan YY, Flavell RA (2005) Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc Natl Acad Sci USA 102(14):5126–5131PubMedCentralPubMedGoogle Scholar
  204. 204.
    Wan YY, Chi H et al (2006) The kinase TAK1 integrates antigen and cytokine receptor signaling for T cell development, survival and function. Nat Immunol 7(8):851–858PubMedGoogle Scholar
  205. 205.
    Wang J, Huizinga TW et al (2009) De novo generation and enhanced suppression of human CD4+CD25+ regulatory T cells by retinoic acid. J Immunol 183(6):4119–4126PubMedGoogle Scholar
  206. 206.
    Wang KC, Yang YW et al (2011) A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature 472(7341):120–124PubMedCentralPubMedGoogle Scholar
  207. 207.
    Wei G, Wei L et al (2009) Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity 30(1):155–167PubMedCentralPubMedGoogle Scholar
  208. 208.
    Weiss JM, Bilate AM et al (2012) Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells. J Exp Med 209(10):1723–1742, S1721Google Scholar
  209. 209.
    Whiteside TL (2012) What are regulatory T cells (Treg) regulating in cancer and why? Semin Cancer Biol 22(4):327–334PubMedCentralPubMedGoogle Scholar
  210. 210.
    Wildin RS, Freitas A (2005) IPEX and FOXP3: clinical and research perspectives. J Autoimmun 25(Suppl):56–62PubMedGoogle Scholar
  211. 211.
    Wildin RS, Ramsdell F et al (2001) X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 27(1):18–20PubMedGoogle Scholar
  212. 212.
    Wing K, Onishi Y et al (2008) CTLA-4 control over Foxp3+ regulatory T cell function. Science 322(5899):271–275PubMedGoogle Scholar
  213. 213.
    Wong J, Obst R et al (2007) Adaptation of TCR repertoires to self-peptides in regulatory and nonregulatory CD4+ T cells. J Immunol 178(11):7032–7041PubMedGoogle Scholar
  214. 214.
    Xufre C, Costa M et al (2013) Low frequency of GITR+ T cells in ex vivo and in vitro expanded Treg cells from type 1 diabetic patients. Int Immunol 25(10):563–574PubMedGoogle Scholar
  215. 215.
    Yadav M, Louvet C et al (2012) Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo. J Exp Med 209(10):1713–1722, S1711–1719Google Scholar
  216. 216.
    Yadav M, Stephan S et al (2013) Peripherally induced tregs—role in immune homeostasis and autoimmunity. Front Immunol 4:232PubMedCentralPubMedGoogle Scholar
  217. 217.
    Yan B, Ye S et al (2008) Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells. Arthritis Rheum 58(3):801–812PubMedGoogle Scholar
  218. 218.
    Yang W, Xu Y (2013) Clinical significance of Treg cell frequency in acute myeloid leukemia. Int J Hematol 98(5):558–562PubMedGoogle Scholar
  219. 219.
    Yang ZZ, Novak AJ et al (2006) Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma. Blood 107(9):3639–3646PubMedCentralPubMedGoogle Scholar
  220. 220.
    Yates J, Whittington A et al (2008) Natural regulatory T cells: number and function are normal in the majority of patients with lupus nephritis. Clin Exp Immunol 153(1):44–55PubMedCentralPubMedGoogle Scholar
  221. 221.
    Zhan Y, Funda DP et al (2004) TCR-mediated activation promotes GITR upregulation in T cells and resistance to glucocorticoid-induced death. Int Immunol 16(9):1315–1321Google Scholar
  222. 222.
    Zhao SS, Li XM et al (2008) Expression of CD4+CD25+CD127(low/-) T cells in patients with systemic lupus erythematosus. Zhonghua Yi Xue Za Zhi 88(7):453–456PubMedGoogle Scholar
  223. 223.
    Zheng SG, Gray JD et al (2002) Generation ex vivo of TGF-beta-producing regulatory T cells from CD4+CD25− precursors. J Immunol 169(8):4183–4189PubMedGoogle Scholar
  224. 224.
    Zheng SG, Wang JH et al (2006) TGF-beta requires CTLA-4 early after T cell activation to induce FoxP3 and generate adaptive CD4+CD25+ regulatory cells. J Immunol 176(6):3321–3329PubMedGoogle Scholar
  225. 225.
    Zheng SG, Wang J et al (2007) IL-2 is essential for TGF-beta to convert naive CD4+CD25− cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells. J Immunol 178(4):2018–2027PubMedGoogle Scholar
  226. 226.
    Zheng Y, Josefowicz SZ et al (2007) Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 445(7130):936–940PubMedGoogle Scholar
  227. 227.
    Zheng Y, Chaudhry A et al (2009) Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature 458(7236):351–356PubMedCentralPubMedGoogle Scholar
  228. 228.
    Zheng Y, Josefowicz S et al (2010) Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 463(7282):808–812PubMedCentralPubMedGoogle Scholar
  229. 229.
    Zhou G, Levitsky HI (2007) Natural regulatory T-cells and de novo-induced regulatory T-cells contribute independently to tumor-specific tolerance. J Immunol 178(4):2155–2162PubMedGoogle Scholar
  230. 230.
    Zhou X, Bailey-Bucktrout SL et al (2009) Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T-cells in vivo. Nat Immunol 10(9):1000–1007PubMedCentralPubMedGoogle Scholar
  231. 231.
    Zunino SJ, Storms DH et al (2007) Diets rich in polyphenols and vitamin A inhibit the development of type I autoimmune diabetes in nonobese diabetic mice. J Nutr 137(5):1216–1221PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2014

Authors and Affiliations

  • Miranda Piccioni
    • 1
  • Zuojia Chen
    • 1
  • Andy Tsun
    • 1
    • 2
  • Bin Li
    • 1
  1. 1.Key Laboratory of Molecular Virology and Immunology, Unit of Molecular Immunology, Institute Pasteur of Shanghai, Institutes for Biological SciencesChinese Academy of SciencesShanghaiChina
  2. 2.New Drug and Cell Line Development, Department of Process DevelopmentInnovent Biologics IncSuzhouChina

Personalised recommendations